Your browser doesn't support javascript.
loading
Use and timing of referral to specialized palliative care services for people with cancer: A mortality follow-back study among treating physicians in Belgium.
Vanbutsele, Gaëlle; Deliens, Luc; Cocquyt, Veronique; Cohen, Joachim; Pardon, Koen; Chambaere, Kenneth.
Affiliation
  • Vanbutsele G; End-of-Life Care Research group, Vrije Universiteit Brussel (VUB) & Ghent University, Brussels, Belgium.
  • Deliens L; Department of Public Health and Primary Care, Ghent University, Ghent, Belgium.
  • Cocquyt V; End-of-Life Care Research group, Vrije Universiteit Brussel (VUB) & Ghent University, Brussels, Belgium.
  • Cohen J; Department of Public Health and Primary Care, Ghent University, Ghent, Belgium.
  • Pardon K; Department of Medical Oncology, Ghent University Hospital, Ghent, Belgium.
  • Chambaere K; End-of-Life Care Research group, Vrije Universiteit Brussel (VUB) & Ghent University, Brussels, Belgium.
PLoS One ; 14(1): e0210056, 2019.
Article de En | MEDLINE | ID: mdl-30653508
ABSTRACT

BACKGROUND:

Referral to specialized palliative care services (SPCS) occurs often late in the illness trajectory but may differ across cancer types. We examined differences between cancer types in the use and timing of referral to specialized palliative care services (SPCS) and in the reasons for non-referral.

METHODS:

We conducted a population-based mortality follow-back survey among physicians who certified a representative sample of deaths in Flanders, Belgium. We focused only on sampled death cases of cancer (n = 2392). The questionnaire asked about the use of the existing types of SPCS and the timing of referral to these services.

RESULTS:

Response rate was 58% (1394/2392). Patients who died from breast, respiratory, head and neck, genitourinary or gastrointestinal cancer had higher chances of using SPCS compared to hematologic cancer patients. The most prevalent reason for non-referral was that regular care sufficiently addressed palliative and supportive care needs (51%). This differed significantly between cancer types ranging from 77,8% for breast cancer and 42.1% for hematologic cancer. A second prevalent reason for not using SPCS was that it was not meaningful (enough) (23.9%), particularly for hematologic malignancies (35,1%) and only in 5.3% for breast cancer.

CONCLUSION:

Differences in referral across different types of cancer were found. Referral is more often delayed or not initiated for patients with hematologic cancer, possibly due to differences in illness trajectory. An influencing reason is that physicians perceive palliative care as not meaningful or not meaningful enough for these patients which may be linked to the uncertainty in the disease trajectory of hematologic malignancies.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Soins palliatifs / Orientation vers un spécialiste / Soins terminaux / Tumeurs Type d'étude: Observational_studies Limites: Adolescent / Adult / Aged / Child / Child, preschool / Humans / Infant / Middle aged Pays/Région comme sujet: Europa Langue: En Journal: PLoS One Sujet du journal: CIENCIA / MEDICINA Année: 2019 Type de document: Article Pays d'affiliation: Belgique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Soins palliatifs / Orientation vers un spécialiste / Soins terminaux / Tumeurs Type d'étude: Observational_studies Limites: Adolescent / Adult / Aged / Child / Child, preschool / Humans / Infant / Middle aged Pays/Région comme sujet: Europa Langue: En Journal: PLoS One Sujet du journal: CIENCIA / MEDICINA Année: 2019 Type de document: Article Pays d'affiliation: Belgique
...